Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters











Publication year range
1.
PLoS One ; 19(6): e0304659, 2024.
Article in English | MEDLINE | ID: mdl-38923959

ABSTRACT

INTRODUCTION: Peer-reviewed literature is commonly used to assess academic progress and research excellency. However, representation in authorship of global health publications is biased and unfair. In order to shed light on current gaps towards attaining gender equality in scientific production and shift power asymmetries in global health research, we conducted an assessment of authorship trends from 1972 to 2021 with a focus on gender and geographic representation in scientific articles authored or co-authored by researchers affiliated with UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP). METHODS: We searched PubMed, Web of Science, and HRP public reports for publications where at least one author was affiliated with HRP. Our main outcome measures were author gender and location of author affiliation, classified by region and country income group. We used descriptive statistics to characterize the publications under analysis as well as the total number of authors from the included papers. We applied a logistic regression model to explore associations between author gender and other characteristics of published articles and a time series analysis to assess how time can influence the inclusion of women as authors in a publication. Python and R were used for all analyses. RESULTS: A total of 1,484 publications with 14,424 listed authors representing 5,950 unique authors were included in our analysis: 42.5% were female, 35.1% male, and 22.4% unknown (p<0.0001). First authorship was more likely female (56.9%) and from a high-income country (74.6%, p<0.0001) while last authorship was mostly male (53.7%) also from a high-income country (82.5%, p<0.0001). Females more frequently published papers using qualitative data (61.4%) and reviews/estimates (59.4%) while men published more case control (70.7%) and randomised controlled studies (53.0%), p<0.0001. The adjusted odds of there being a female author increased 4% for every additional year that passed. CONCLUSION: While there are more females authoring articles as compared to the past, they are still lagging behind with regards to seniority and prestige. Likewise, female representation is closely tied to what institution they are affiliated with and where that institution is located. Global health research institutions need to actively promote change by ensuring women are included in research and research outputs, giving them opportunities to lead.


Subject(s)
Authorship , Publications , Reproductive Health , Humans , Female , Male , Reproductive Health/statistics & numerical data , Publications/statistics & numerical data , Sexual Health , Global Health
2.
BMJ Open ; 14(2): e073084, 2024 Feb 21.
Article in English | MEDLINE | ID: mdl-38387982

ABSTRACT

OBJECTIVE: To identify and summarise the evidence on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA detection and persistence in body fluids associated with sexual activity (saliva, semen, vaginal secretion, urine and faeces/rectal secretion). ELIGIBILITY: All studies that reported detection of SARS-CoV-2 in saliva, semen, vaginal secretion, urine and faeces/rectal swabs. INFORMATION SOURCES: The WHO COVID-19 database from inception to 20 April 2022. RISK OF BIAS ASSESSMENT: The National Institutes of Health tools. SYNTHESIS OF RESULTS: The proportion of patients with positive results for SARS-CoV-2 and the proportion of patients with a viral duration/persistence of at least 14 days in each fluid was calculated using fixed or random effects models. INCLUDED STUDIES: A total of 182 studies with 10 023 participants. RESULTS: The combined proportion of individuals with detection of SARS-CoV-2 was 82.6% (95% CI: 68.8% to 91.0%) in saliva, 1.6% (95% CI: 0.9% to 2.6%) in semen, 2.7% (95% CI: 1.8% to 4.0%) in vaginal secretion, 3.8% (95% CI: 1.9% to 7.6%) in urine and 31.8% (95% CI: 26.4% to 37.7%) in faeces/rectal swabs. The maximum viral persistence for faeces/rectal secretions was 210 days, followed by semen 121 days, saliva 112 days, urine 77 days and vaginal secretions 13 days. Culturable SARS-CoV-2 was positive for saliva and faeces. LIMITATIONS: Scarcity of longitudinal studies with follow-up until negative results. INTERPRETATION: SARS-CoV-2 RNA was detected in all fluids associated with sexual activity but was rare in semen and vaginal secretions. Ongoing droplet precautions and awareness of the potential risk of contact with faecal matter/rectal mucosa are needed. PROSPERO REGISTRATION NUMBER: CRD42020204741.


Subject(s)
Body Fluids , COVID-19 , SARS-CoV-2 , Sexual Behavior , Virus Shedding , Humans , COVID-19/virology , Body Fluids/virology , Female , Saliva/virology , RNA, Viral/analysis , Semen/virology , Male , Feces/virology , Feces/chemistry , Vagina/virology
3.
BMJ Open ; 13(12): e070677, 2023 12 22.
Article in English | MEDLINE | ID: mdl-38135336

ABSTRACT

OBJECTIVES: Daily calcium supplements are recommended for pregnant women from 20 weeks' gestation to prevent pre-eclampsia in populations with low dietary calcium intake. We aimed to improve understanding of barriers and facilitators for calcium supplement intake during pregnancy to prevent pre-eclampsia. DESIGN: Mixed-method systematic review, with confidence assessed using the Grading of Recommendations, Assessment, Development and Evaluations-Confidence in the Evidence from Reviews of Qualitative research approach. DATA SOURCES: MEDLINE and EMBASE (via Ovid), CINAHL and Global Health (via EBSCO) and grey literature databases were searched up to 17 September 2022. ELIGIBILITY CRITERIA: We included primary qualitative, quantitative and mixed-methods studies reporting implementation or use of calcium supplements during pregnancy, excluding calcium fortification and non-primary studies. No restrictions were imposed on settings, language or publication date. DATA EXTRACTION AND SYNTHESIS: Two independent reviewers extracted data and assessed risk of bias. We analysed the qualitative data using thematic synthesis, and quantitative findings were thematically mapped to qualitative findings. We then mapped the results to behavioural change frameworks to identify barriers and facilitators. RESULTS: Eighteen reports from nine studies were included in this review. Women reported barriers to consuming calcium supplements included limited knowledge about calcium supplements and pre-eclampsia, fears and experiences of side effects, varying preferences for tablets, dosing, working schedules, being away from home and taking other supplements. Receiving information regarding pre-eclampsia and safety of calcium supplement use from reliable sources, alternative dosing options, supplement reminders, early antenatal care, free supplements and support from families and communities were reported as facilitators. Healthcare providers felt that consistent messaging about benefits and risks of calcium, training, and ensuring adequate staffing and calcium supply is available would be able to help them in promoting calcium. CONCLUSION: Relevant stakeholders should consider the identified barriers and facilitators when formulating interventions and policies on calcium supplement use. These review findings can inform implementation to ensure effective and equitable provision and scale-up of calcium interventions. PROSPERO REGISTRATION NUMBER: CRD42021239143.


Subject(s)
Pre-Eclampsia , Female , Pregnancy , Humans , Pre-Eclampsia/prevention & control , Calcium/therapeutic use , Dietary Supplements , Calcium, Dietary , Prenatal Care/methods
6.
Rev Panam Salud Publica ; 47, 2023. Migración y Salud
Article in Spanish | PAHO-IRIS | ID: phr-57169

ABSTRACT

[EXTRACTO] La evidencia que surge de este número especial destaca las necesidades específicas de las personas migrantes latinoamericanas respecto a la respuesta de los sistemas de salud a la salud sexual y reproductiva y las enfermedades infecciosas. Si bien hay políticas relacionadas con la salud de las personas migrantes y refugiadas, y se observan esfuerzos para fortalecer los sistemas de salud en los países de acogida, las personas migrantes de América Latina aún enfrentan una gran cantidad de dificultades al recurrir a los sistemas de salud para atender sus necesidades de SDSR. La pandemia de COVID-19 exacerbó aún más estos desafíos. Se necesitan políticas de SDSR que puedan llevarse a la práctica para poder responder adecuadamente a las necesidades de las personas migrantes.


Subject(s)
COVID-19 , Human Migration , Transients and Migrants , Migrant-Receiving Society , Reproductive Rights , Sexual Health , Venezuela , Central America
7.
Rev Panam Salud Publica ; 47, 2023. Migración y Salud
Article in English | PAHO-IRIS | ID: phr-57168

ABSTRACT

[EXTRACT] The evidence emerging from this special issue highlights the specific needs of Latin American migrants with regards to health system response to sexual and reproductive health and infectious diseases. While policies relating to the health of ref- ugees and migrants and efforts to strengthen health systems in host countries exist, migrants in Latin America still face a myr- iad of challenges when navigating health systems in addressing their SRHR needs. The COVID-19 pandemic further exacer- bated these challenges. Specific SRHR actionable policies are needed to ensure the needs of migrants are fully met.


Subject(s)
COVID-19 , Human Migration , Transients and Migrants , Migrant-Receiving Society , Reproductive Rights , Sexual Health , Venezuela , Central America
10.
J Urban Health ; 92(5): 785-99, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26245466

ABSTRACT

Urbanization promotes economy, mobility, access, and availability of resources, but on the other hand, generates higher levels of pollution, violence, crime, and mental distress. The health consequences of the agglomeration of people living close together are not fully understood. Particularly, it remains unclear how variations in the population size across cities impact the health of the population. We analyze the deviations from linearity of the scaling of several health-related quantities, such as the incidence and mortality of diseases, external causes of death, wellbeing, and health care availability, in respect to the population size of cities in Brazil, Sweden, and the USA. We find that deaths by non-communicable diseases tend to be relatively less common in larger cities, whereas the per capita incidence of infectious diseases is relatively larger for increasing population size. Healthier lifestyle and availability of medical support are disproportionally higher in larger cities. The results are connected with the optimization of human and physical resources and with the non-linear effects of social networks in larger populations. An urban advantage in terms of health is not evident, and using rates as indicators to compare cities with different population sizes may be insufficient.


Subject(s)
Cities/epidemiology , Health , Urban Population , Brazil/epidemiology , Cause of Death , Health/statistics & numerical data , Health Services Accessibility/statistics & numerical data , Humans , Mortality , Nonlinear Dynamics , Population Density , Sweden/epidemiology , United States/epidemiology , Urban Population/statistics & numerical data
11.
PLoS Med ; 8(8): e1001083, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21918643

ABSTRACT

BACKGROUND: Population movements following disasters can cause important increases in morbidity and mortality. Without knowledge of the locations of affected people, relief assistance is compromised. No rapid and accurate method exists to track population movements after disasters. We used position data of subscriber identity module (SIM) cards from the largest mobile phone company in Haiti (Digicel) to estimate the magnitude and trends of population movements following the Haiti 2010 earthquake and cholera outbreak. METHODS AND FINDINGS: Geographic positions of SIM cards were determined by the location of the mobile phone tower through which each SIM card connects when calling. We followed daily positions of SIM cards 42 days before the earthquake and 158 days after. To exclude inactivated SIM cards, we included only the 1.9 million SIM cards that made at least one call both pre-earthquake and during the last month of study. In Port-au-Prince there were 3.2 persons per included SIM card. We used this ratio to extrapolate from the number of moving SIM cards to the number of moving persons. Cholera outbreak analyses covered 8 days and tracked 138,560 SIM cards. An estimated 630,000 persons (197,484 Digicel SIM cards), present in Port-au-Prince on the day of the earthquake, had left 19 days post-earthquake. Estimated net outflow of people (outflow minus inflow) corresponded to 20% of the Port-au-Prince pre-earthquake population. Geographic distribution of population movements from Port-au-Prince corresponded well with results from a large retrospective, population-based UN survey. To demonstrate feasibility of rapid estimates and to identify areas at potentially increased risk of outbreaks, we produced reports on SIM card movements from a cholera outbreak area at its immediate onset and within 12 hours of receiving data. CONCLUSIONS: Results suggest that estimates of population movements during disasters and outbreaks can be delivered rapidly and with potentially high validity in areas with high mobile phone use.


Subject(s)
Cell Phone/statistics & numerical data , Disasters , Earthquakes , Relief Work/organization & administration , Cholera/prevention & control , Demography , Disease Outbreaks , Geography , Haiti , Humans , International Cooperation , Locomotion , Relief Work/economics
SELECTION OF CITATIONS
SEARCH DETAIL